NONLINEAR PHARMACOKINETIC CHARACTERISTICS OF 5-FLUOROURACIL (5-FU) IN COLORECTAL-CANCER PATIENTS

被引：50
|
作者：
SCHAAF, LJ
DOBBS, BR
EDWARDS, IR
PERRIER, DG
机构：
[1] UNIV OTAGO,SCH MED,DEPT PHARM,DUNEDIN,NEW ZEALAND
[2] UNIV OTAGO,SCH MED,MRC NEW ZEALAND,TOXICOL RES UNIT,DUNEDIN,NEW ZEALAND
来源：
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1987年 / 32卷 / 04期
关键词：
D O I：
10.1007/BF00543978
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：411 / 418
页数：8
相关论文
共 50 条
  • [1] 5-FLUOROURACIL (5-FU) COMBINED WITH LEUCOVORIN (LV) IN PATIENTS WITH ADVANCED 5-FU RESISTANT COLORECTAL-CANCER
    VANGROENINGEN, CJ
    PETERS, GJ
    PINEDO, HM
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 202 - 202
  • [2] THE RELATIONSHIP BETWEEN PLASMA PHARMACOKINETICS AND TISSUE METABOLITES OF 5-FLUOROURACIL (5-FU) IN PATIENTS WITH COLORECTAL-CANCER
    FINAN, PJ
    CHISHOLM, EM
    WOODHOUSE, L
    GILES, GR
    [J]. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1987, 13 (04): : 349 - 353
  • [3] Pharmacokinetic (PK) guided optimization of 5-fluorouracil (5-FU) dosing in the treatment of patients with colorectal cancer (CRC)
    Goal, Gaurav
    Chu, Edward
    Sun, Min
    Meisner, Dennis James
    Lee, James J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [4] Methotrexate (MTX) and 5-fluorouracil (5-FU) in advanced colorectal cancer patients previously treated with adjuvant 5-FU
    Pronzato, P
    Vaira, F
    Viganni, A
    Losardo, P
    Bertelli, G
    [J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A : 760 - 760
  • [5] Doxifluridine in colorectal cancer patients resistant to 5-fluorouracil (5-FU) containing regimens
    Bajetta, E
    DiBartolomeo, M
    Somma, L
    DelVecchio, M
    Artale, S
    Zunino, F
    Bignami, P
    Magnani, E
    Buzzoni, R
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 (04) : 687 - 690
  • [6] COMBINATION CHEMOTHERAPY CONTAINING SEMUSTINE (MECCNU) IN PATIENTS WITH ADVANCED COLORECTAL-CANCER PREVIOUSLY TREATED WITH 5-FLUOROURACIL (5-FU)
    ENGSTROM, PF
    MACINTYRE, JM
    DOUGLASS, HO
    MUGGIA, F
    MITTELMAN, A
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1983, 6 (02): : 175 - 180
  • [7] A COMPARISON OF 5-FLUOROURACIL(5-FU) LEUCOVORIN WITH OTHER CURRENT CHEMOTHERAPEUTIC REGIMENS IN THE TREATMENT OF METASTASIZING COLORECTAL-CANCER
    BAUR, M
    SCHLAPPACK, O
    HAVELEC, L
    MADER, R
    MAROSI, C
    SCHEITHAUER, W
    DITTRICH, C
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 1991, 103 (11) : 332 - 339
  • [8] Therapeutic drug monitoring of 5-fluorouracil (5-FU) in the treatment of patients with colorectal cancer (CRC)
    Goel, Gaurav
    Sehgal, Rajesh
    Meisner, Dennis James
    Sun, Min
    Pasricha, Gurleen
    Chu, Edward
    Lee, James J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [9] BAKER ANTIFOL (BAF) IN COMBINATION WITH METHYL CCNU AND 5-FLUOROURACIL (5-FU) FOR THE TREATMENT OF METASTATIC COLORECTAL-CANCER
    SHAW, MT
    HEILBRUN, LK
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 300 - 300
  • [10] HIGH-DOSE LEUCOVORIN (CF), 5-FLUOROURACIL (5-FU) AND CISPLATIN (CIS) CHEMOTHERAPY IN PATIENTS WITH METASTATIC COLORECTAL-CANCER
    SCHEITHAUER, W
    DEPISCH, D
    SCHIESSEL, R
    ZIELINSKI, C
    PREIS, P
    GISSLINGER, H
    LUDWIG, H
    [J]. BLUT, 1988, 57 (04): : 206 - 206
12345